OptiNose (OPTN) Stock Forecast & Price Target

$0.70

+0.02 (+2.95%)

(As of 09/27/2024 ET)

OptiNose - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 2 Analyst Ratings

Sell
0

Hold
0

Buy
2

Based on 2 Wall Street analysts who have issued ratings for OptiNose in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for OPTN.

Consensus Price Target

$4.00
472.25% Upside

According to the 2 analysts' twelve-month price targets for OptiNose, the average price target is $4.00. The highest price target for OPTN is $5.00, while the lowest price target for OPTN is $3.00. The average price target represents a forecasted upside of 472.25% from the current price of $0.70.

Get the Latest News and Ratings for OPTN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for OptiNose and its competitors.

OPTN Analyst Ratings Over Time

Type	Current Forecast 9/29/23 to 9/28/24	1 Month Ago 8/30/23 to 8/29/24	3 Months Ago 7/1/23 to 6/30/24	1 Year Ago 9/29/22 to 9/29/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$4.00	$4.00	$3.67	$4.00
Forecasted Upside	472.25% Upside	273.83% Upside	252.56% Upside	225.20% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Jovine Was Right in 2008—Will You Listen This Time? (Ad)

The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.

Take these 4 steps today to protect your retirement NOW

OPTN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

OPTN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

OptiNose Stock vs. The Competition

Type	OptiNose	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.78	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	472.25% Upside	818.48% Upside	6.14% Upside
News Sentiment Rating	Very Positive News See Recent OPTN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/15/2024	Lake Street Capital 3 of 5 stars		Lower Target	Buy ➝ Buy	$4.00 ➝ $3.00	+169.06%
5/15/2024	HC Wainwright 2 of 5 stars	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00	+344.44%
8/11/2023	Piper Sandler 2 of 5 stars		Lower Target	Overweight ➝ Overweight	$4.00 ➝ $3.00	+142.91%
11/14/2022	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$6.00 ➝ $5.00	+124.21%
10/21/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$5.00	+53.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:28 AM ET.

OPTN Forecast - Frequently Asked Questions

: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for OptiNose is $4.00, with a high forecast of $5.00 and a low forecast of $3.00.
: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OptiNose in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OPTN shares.
: According to analysts, OptiNose's stock has a predicted upside of 472.25% based on their 12-month stock forecasts.
: Analysts like OptiNose more than other "medical" companies. The consensus rating for OptiNose is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OPTN compares to other companies.